1981

CELLULAR IMMUNITY DEFICIENCY
Int Congr Ser; 502(part1):155-162 1980. Unique Identifier : AIDSLINE ICDB/81611714
Bendixen G; Copenhagen Univ. Hosp., Rigshospitalet, Tagensvej 18, 2200; Copenhagen, Denmark
The etiology, diagnosis, monitoring, and therapy of cell-mediated immune deficiency (CMID) is discussed. CMID is a condition in which T-lymphocytes, which are developmentally and functionally dependent on the thymus, are absent or deficient at some level. CMID can be subclassified into two distinct types: the congenit


VIROLOGY AND IMMUNE MECHANISMS
Cancer; 47(5,Suppl):1091-1094 1981. Unique Identifier : AIDSLINE ICDB/81611965
Merigan TC; Div. Infectious Diseases, Dept. Medicine, Stanford Univ. Sch.; Medicine, Stanford, CA, 94305
Epstein-Barr virus and hepatitis B virus are two agents which chronically infect man and have been associated with specific neoplasms. Such findings point the way to new methods of control and detection of human malignancies. Furthermore, immunosuppression is another major factor underlying the development of certain


LACK OF COVALENT BINDING TO RAT LIVER DNA OF THE HYPOLIPIDEMIC DRUGS CLOFIBRATE AND FENOFIBRATE
Toxicol Lett; 7(4/5):305-310 1981. Unique Identifier : AIDSLINE ICDB/81612389
Von Daniken A; Lutz WK; Schlatter C; Inst. Toxicology, Swiss Federal Inst. Technology, Schwerzenbach; CH-8603, Switzerland
Labeled clofibric or fenofibric acid was administered po to Sprague-Dawley derived SIV 50 rats, and 10 hr later, the animals were sacrificed and the nuclear DNA and protein were isolated from the livers. 14C-Label was detected in protein (9-78 disintegrations/min); however, radioactivity levels in the DNA were just ab


Prevalence of hepatitis B e antigen and its antibody in various HBsAg carrier populations.
Am J Epidemiol. 1981 Feb;113(2):113-21. Unique Identifier : AIDSLINE MED/81130778
Szmuness W; Neurath AR; Stevens CE; Strick N; Harley EJ
A total of 749 persistent carriers of hepatitis B surface antigen (HBsAg) were tested for hepatitis B e antigen/antibody to e antigen (HBeAg/anti-HBe) by a radioimmunoassay method. The prevalence of HBeAg was found to be: 9.1% in carrier-blood donors, 10.3% in mentally retarded patients without Down s syndrome, 23.6%


Nosocomial infections in immunocompromised children.
Am J Med. 1981 Feb;70(2):412-6. Unique Identifier : AIDSLINE MED/81130863
Hughes WT; Townsend TR
Within the last decade several advances in medicine have resulted in extended longevity of children with cancer, cystic fibrosis, certain congenital immunodeficiency disorders, chronic renal diseases and aplastic anemia. Forthwith, the population of such immunocompromised children has increased and accounts for a grea


X-linked lymphoproliferative syndrome. An immunodeficiency disorder with acquired agammaglobulinemia, fatal infectious mononucleosis, or malignant lymphoma.
Arch Pathol Lab Med. 1981 Mar;105(3):119-21. Unique Identifier : AIDSLINE MED/81132788
Purtilo DT
The X-linked lymphoproliferative syndrome (XLP) is characterized by a combined variable immunodeficiency with vulnerability to Epstein-Barr virus (EBV)-induced fatal or chronic infectious mononucleosis, acquired agammaglobulinemia, aplastic anemia, or malignant B cell lymphomas. Diagnosis of XLP requires documentation


Primate type-C oncoviruses.
Biochim Biophys Acta. 1980 Nov 26;605(4):461-87. Unique Identifier : AIDSLINE MED/81110559
Nooter K; Bentvelzen P
Biological and antigenic characteristics of HEL-12 virus.
J Gen Virol. 1980 Oct;50(2):247-57. Unique Identifier : AIDSLINE MED/81118903
Bergholz CM; Reynolds JT; Panem S
The biological and antigenic properties of HEL-12 virus have been compared with gibbon ape lymphosarcoma virus (GALV) and simian sarcoma and simian sarcoma-associated viruses, SiSV and SSAV, respectively, HEL-12 virus did not transform human or marmoset fibroblasts but rescued SiSV focus-forming activity from non-prod


Primary Epstein-Barr virus infection in early childhood.
Arch Dis Child. 1981 Jan;56(1):49-52. Unique Identifier : AIDSLINE MED/81132283
Krabbe S; Hesse J; Uldall P
In a prospective study 43 consecutive children in hospital, aged between 6 months and 7 years and displaying at least one of the clinical signs of infectious mononucleosis (IM), were investigated for Epstein-Barr (EB) virus-specific IgM antibodies by an indirect immunofluorescence test. On this basis EB virus infectio



This information is designed to support, not replace, the relationship that exists between you and your doctor.
©1980, 1981. AEGiS.